Mumbai: With Novo Nordisk’s Semaglutide patent due for expiry in various markets, India’s leading generic drugs manufacturer Biocon has signed a licensing agreement with Ajanta Pharma to market its version...
Mumbai: India’s pharmaceutical market continues to grow in single digits, though the growth has remained consistent so far, a report by Nomura has revealed. Sales have grown 9% YoY for...
Mumbai: Donald Trump has slapped a 100% pharma tariff on branded imports. He refers to it as “national security.” For India’s $10 billion pharma export machine, it’s a bitter pill....
